Novelix Pharmaceuticals standalone net profit declines 35.71% in the March 2025 quarter
28 - May - 2025 12:00 | 16 days ago
Net profit of Novelix Pharmaceuticals declined 35.71% to Rs 0.18 crore in the quarter ended March 2025 as against Rs 0.28 crore during the previous quarter ended March 2024. Sales rose 2383.33% to Rs 20.86 crore in the quarter ended March 2025 as against Rs 0.84 crore during the previous quarter ended March 2024.
For the full year,net profit rose 700.00% to Rs 0.08 crore in the year ended March 2025 as against Rs 0.01 crore during the previous year ended March 2024. Sales rose 627.96% to Rs 30.72 crore in the year ended March 2025 as against Rs 4.22 crore during the previous year ended March 2024.
Novelix Pharmaceuticals standalone net profit declines 35.71% in the March 2025 quarter
28 - May - 2025 12:00 | 16 days ago
Net profit of Novelix Pharmaceuticals declined 35.71% to Rs 0.18 crore in the quarter ended March 2025 as against Rs 0.28 crore during the previous quarter ended March 2024. Sales rose 2383.33% to Rs 20.86 crore in the quarter ended March 2025 as against Rs 0.84 crore during the previous quarter ended March 2024.
For the full year,net profit rose 700.00% to Rs 0.08 crore in the year ended March 2025 as against Rs 0.01 crore during the previous year ended March 2024. Sales rose 627.96% to Rs 30.72 crore in the year ended March 2025 as against Rs 4.22 crore during the previous year ended March 2024.
Novelix Pharmaceuticals standalone net profit declines 35.71% in the March 2025 quarter
28 - May - 2025 12:00 | 16 days ago
Net profit of Novelix Pharmaceuticals declined 35.71% to Rs 0.18 crore in the quarter ended March 2025 as against Rs 0.28 crore during the previous quarter ended March 2024. Sales rose 2383.33% to Rs 20.86 crore in the quarter ended March 2025 as against Rs 0.84 crore during the previous quarter ended March 2024.
For the full year,net profit rose 700.00% to Rs 0.08 crore in the year ended March 2025 as against Rs 0.01 crore during the previous year ended March 2024. Sales rose 627.96% to Rs 30.72 crore in the year ended March 2025 as against Rs 4.22 crore during the previous year ended March 2024.